Transient increase of interferon-stimulated genes and no clinical benefit by chloroquine treatment during acute simian immunodeficiency virus infection of macaques

Monica Vaccari, Claudio Fenizia, Zhong Min Ma, Anna Hryniewicz, Adriano Boasso, Melvin N. Doster, Chris J Miller, Niklas Lindegardh, Joel Tarning, Alan L. Landay, Gene M. Shearer, Genoveffa Franchini

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Simian immunodeficiency virus (SIV) infection leads to AIDS in experimentally infected Rhesus macaques similarly to HIV-infected humans. In contrast, SIV infection of natural hosts is characterized by a down-regulation of innate acute responses to the virus within a few weeks of infection and results in limited pathology. Chloroquine (CQ) has been used in the treatment or prevention of malaria and has recently been shown to cause a decrease of immune activation and CD4 cell loss in HIV-infected individuals treated with antiretroviral therapy. Here, we treated Rhesus macaques with CQ during the acute phase of SIVmac251 infection with the intent to decrease viral-induced immune activation and possibly limit disease progression. Contrary to what was expected, CQ treatment resulted in a temporary increased expression of interferon (IFN)-stimulating genes and it worsened the recovery of CD4 + T cells in the blood. Our findings confirm recent results observed in asymptomatic HIV-infected patients and suggest that CQ does not provide an obvious benefit in the absence of antiretroviral therapy.

Original languageEnglish (US)
Pages (from-to)355-362
Number of pages8
JournalAIDS Research and Human Retroviruses
Volume30
Issue number4
DOIs
StatePublished - Apr 1 2014

Fingerprint

Simian Immunodeficiency Virus
Chloroquine
Macaca
Virus Diseases
Interferons
HIV
Macaca mulatta
Genes
Therapeutics
Infection
Malaria
Disease Progression
Acquired Immunodeficiency Syndrome
Down-Regulation
Pathology
Viruses
T-Lymphocytes

ASJC Scopus subject areas

  • Immunology
  • Virology
  • Infectious Diseases

Cite this

Transient increase of interferon-stimulated genes and no clinical benefit by chloroquine treatment during acute simian immunodeficiency virus infection of macaques. / Vaccari, Monica; Fenizia, Claudio; Ma, Zhong Min; Hryniewicz, Anna; Boasso, Adriano; Doster, Melvin N.; Miller, Chris J; Lindegardh, Niklas; Tarning, Joel; Landay, Alan L.; Shearer, Gene M.; Franchini, Genoveffa.

In: AIDS Research and Human Retroviruses, Vol. 30, No. 4, 01.04.2014, p. 355-362.

Research output: Contribution to journalArticle

Vaccari, M, Fenizia, C, Ma, ZM, Hryniewicz, A, Boasso, A, Doster, MN, Miller, CJ, Lindegardh, N, Tarning, J, Landay, AL, Shearer, GM & Franchini, G 2014, 'Transient increase of interferon-stimulated genes and no clinical benefit by chloroquine treatment during acute simian immunodeficiency virus infection of macaques', AIDS Research and Human Retroviruses, vol. 30, no. 4, pp. 355-362. https://doi.org/10.1089/aid.2013.0218
Vaccari, Monica ; Fenizia, Claudio ; Ma, Zhong Min ; Hryniewicz, Anna ; Boasso, Adriano ; Doster, Melvin N. ; Miller, Chris J ; Lindegardh, Niklas ; Tarning, Joel ; Landay, Alan L. ; Shearer, Gene M. ; Franchini, Genoveffa. / Transient increase of interferon-stimulated genes and no clinical benefit by chloroquine treatment during acute simian immunodeficiency virus infection of macaques. In: AIDS Research and Human Retroviruses. 2014 ; Vol. 30, No. 4. pp. 355-362.
@article{73bfd0f74b574f93b6bf83d470efc940,
title = "Transient increase of interferon-stimulated genes and no clinical benefit by chloroquine treatment during acute simian immunodeficiency virus infection of macaques",
abstract = "Simian immunodeficiency virus (SIV) infection leads to AIDS in experimentally infected Rhesus macaques similarly to HIV-infected humans. In contrast, SIV infection of natural hosts is characterized by a down-regulation of innate acute responses to the virus within a few weeks of infection and results in limited pathology. Chloroquine (CQ) has been used in the treatment or prevention of malaria and has recently been shown to cause a decrease of immune activation and CD4 cell loss in HIV-infected individuals treated with antiretroviral therapy. Here, we treated Rhesus macaques with CQ during the acute phase of SIVmac251 infection with the intent to decrease viral-induced immune activation and possibly limit disease progression. Contrary to what was expected, CQ treatment resulted in a temporary increased expression of interferon (IFN)-stimulating genes and it worsened the recovery of CD4 + T cells in the blood. Our findings confirm recent results observed in asymptomatic HIV-infected patients and suggest that CQ does not provide an obvious benefit in the absence of antiretroviral therapy.",
author = "Monica Vaccari and Claudio Fenizia and Ma, {Zhong Min} and Anna Hryniewicz and Adriano Boasso and Doster, {Melvin N.} and Miller, {Chris J} and Niklas Lindegardh and Joel Tarning and Landay, {Alan L.} and Shearer, {Gene M.} and Genoveffa Franchini",
year = "2014",
month = "4",
day = "1",
doi = "10.1089/aid.2013.0218",
language = "English (US)",
volume = "30",
pages = "355--362",
journal = "AIDS Research and Human Retroviruses",
issn = "0889-2229",
publisher = "Mary Ann Liebert Inc.",
number = "4",

}

TY - JOUR

T1 - Transient increase of interferon-stimulated genes and no clinical benefit by chloroquine treatment during acute simian immunodeficiency virus infection of macaques

AU - Vaccari, Monica

AU - Fenizia, Claudio

AU - Ma, Zhong Min

AU - Hryniewicz, Anna

AU - Boasso, Adriano

AU - Doster, Melvin N.

AU - Miller, Chris J

AU - Lindegardh, Niklas

AU - Tarning, Joel

AU - Landay, Alan L.

AU - Shearer, Gene M.

AU - Franchini, Genoveffa

PY - 2014/4/1

Y1 - 2014/4/1

N2 - Simian immunodeficiency virus (SIV) infection leads to AIDS in experimentally infected Rhesus macaques similarly to HIV-infected humans. In contrast, SIV infection of natural hosts is characterized by a down-regulation of innate acute responses to the virus within a few weeks of infection and results in limited pathology. Chloroquine (CQ) has been used in the treatment or prevention of malaria and has recently been shown to cause a decrease of immune activation and CD4 cell loss in HIV-infected individuals treated with antiretroviral therapy. Here, we treated Rhesus macaques with CQ during the acute phase of SIVmac251 infection with the intent to decrease viral-induced immune activation and possibly limit disease progression. Contrary to what was expected, CQ treatment resulted in a temporary increased expression of interferon (IFN)-stimulating genes and it worsened the recovery of CD4 + T cells in the blood. Our findings confirm recent results observed in asymptomatic HIV-infected patients and suggest that CQ does not provide an obvious benefit in the absence of antiretroviral therapy.

AB - Simian immunodeficiency virus (SIV) infection leads to AIDS in experimentally infected Rhesus macaques similarly to HIV-infected humans. In contrast, SIV infection of natural hosts is characterized by a down-regulation of innate acute responses to the virus within a few weeks of infection and results in limited pathology. Chloroquine (CQ) has been used in the treatment or prevention of malaria and has recently been shown to cause a decrease of immune activation and CD4 cell loss in HIV-infected individuals treated with antiretroviral therapy. Here, we treated Rhesus macaques with CQ during the acute phase of SIVmac251 infection with the intent to decrease viral-induced immune activation and possibly limit disease progression. Contrary to what was expected, CQ treatment resulted in a temporary increased expression of interferon (IFN)-stimulating genes and it worsened the recovery of CD4 + T cells in the blood. Our findings confirm recent results observed in asymptomatic HIV-infected patients and suggest that CQ does not provide an obvious benefit in the absence of antiretroviral therapy.

UR - http://www.scopus.com/inward/record.url?scp=84898752676&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898752676&partnerID=8YFLogxK

U2 - 10.1089/aid.2013.0218

DO - 10.1089/aid.2013.0218

M3 - Article

VL - 30

SP - 355

EP - 362

JO - AIDS Research and Human Retroviruses

JF - AIDS Research and Human Retroviruses

SN - 0889-2229

IS - 4

ER -